Doxorubicin production (IMAGE)
Caption
The image shows how the new, optimised strain of bacteria produce an increased amount of doxorubicin. In the center, the primary production machinery (DoxA) is enhanced by a biological 'power supply' (FDX and FDR) and a 'molecular sponge' (DnrV). While the power supply keeps the process running at high speed, the sponge prevents the drug from clogging the system, allowing the engineered cells to produce the medicine with unprecedented purity and a 180% higher yield than standard industrial methods.
Credit
Keith Yamada
Usage Restrictions
Please attribute the image to the creator.
License
Original content